![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Bladder Cancer |
Free Subscription
1 Am J Surg Pathol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Bladder Cancer is free of charge.
Myxoid Pseudotumor Involving the Renal Sinus: Clinicopathologic Study of 33 Cases
Supporting a Distinct Benign Non-neoplastic Lesion.
Am J Surg Pathol. 2023;47:218-223.
PubMed
Abstract available
Evaluation of grade and invasiveness of bladder urothelial carcinoma using
infrared imaging and machine learning.
Analyst. 2022 Dec 16. doi: 10.1039/d2an01583.
PubMed
Abstract available
Bioinformatics analysis of the correlation between m6A RNA methylation regulators
and the immune infiltration and prognosis of bladder cancer.
Ann Transl Med. 2022;10:1386.
PubMed
Abstract available
Bladder Cancer Progression Is Suppressed Through the Heart and Neural Crest
Derivatives Expressed 2-Antisense RNA 1/microRNA-93-5p/Defective in Cullin
Neddylation 1 Domain Containing 3 Axis.
Appl Biochem Biotechnol. 2023 Jan 19. doi: 10.1007/s12010-022-04295.
PubMed
Abstract available
Combination of hyperthermia and intravesical chemotherapy for the treatment of
pT1 stage bladder cancer: A retrospectively clinical study.
Asia Pac J Clin Oncol. 2023 Jan 19. doi: 10.1111/ajco.13931.
PubMed
Abstract available
A multi-institutional retrospective study of open versus laparoscopic
nephroureterectomy focused on the intravesical recurrence.
Asia Pac J Clin Oncol. 2023;19:71-78.
PubMed
Abstract available
Bioinformatics analysis of key biomarkers for bladder cancer.
Biomed Rep. 2022;18:14.
PubMed
Abstract available
Discovery and characterization of orally bioavailable
4-chloro-6-fluoroisophthalamides as covalent PPARG inverse-agonists.
Bioorg Med Chem. 2022;78:117130.
PubMed
Abstract available
Impact of Age at Diagnosis of Bladder Cancer on Survival: A Surveillance,
Epidemiology, and End Results-Based Study 2004-2015.
Cancer Control. 2023;30:10732748231152322.
PubMed
Abstract available
Inherited mutations in Chinese patients with upper tract urothelial carcinoma.
Cell Rep Med. 2023;4:100883.
PubMed
Abstract available
Theranostic targeting of CUB domain containing protein 1 (CDCP1) in multiple
subtypes of bladder cancer.
Clin Cancer Res. 2023 Jan 17:CCR-22-1973. doi: 10.1158/1078-0432.CCR-22-1973.
PubMed
Abstract available
Pathway-guided monitoring of the disease course in bladder cancer with
longitudinal urine proteomics.
Commun Med (Lond). 2023;3:8.
PubMed
Abstract available
Direct and indirect medical costs of bladder cancer in Iran.
Cost Eff Resour Alloc. 2023;21:5.
PubMed
Abstract available
Characterizing treatment resistance in muscle invasive bladder cancer using the
chicken egg chorioallantoic membrane patient-derived xenograft model.
Heliyon. 2022;8:e12570.
PubMed
Abstract available
Immunohistochemical appraisal of epithelial mesenchymal transition type III in
gall bladder cancer.
Indian J Pathol Microbiol. 2023;66:44-53.
PubMed
Abstract available
Editorial Comment to Significance of dorsal bladder neck involvement in
predicting the progression of non-muscle-invasive bladder cancer.
Int J Urol. 2023 Jan 18. doi: 10.1111/iju.15150.
PubMed
Efficacy and safety of 2-micron laser versus conventional trans-urethral
resection of bladder tumor for non-muscle-invasive bladder tumor: A systematic
review and meta-analysis.
J Cancer Res Ther. 2022;18:1894-1902.
PubMed
Abstract available
Efficacy and adverse reactions of intra-arterial chemotherapy in patients with
bladder cancer: A systematic review and meta-analysis.
J Cancer Res Ther. 2022;18:1884-1893.
PubMed
Abstract available
FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With
Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3
mRNA Expression.
J Clin Oncol. 2023;41:629-639.
PubMed
Abstract available
EphrinB2 Inhibition and Pembrolizumab in Metastatic Urothelial Carcinoma.
J Clin Oncol. 2023;41:640-650.
PubMed
Abstract available
Development of resistance to FGFR inhibition in urothelial carcinoma via multiple
pathways in vitro.
J Pathol. 2023;259:220-232.
PubMed
Abstract available
New Gene Therapy for Certain Bladder Cancers.
JAMA. 2023;329:201.
PubMed
Retrospective analysis of 1470-/980-nm dual-wavelength laser en bloc resection
versus transurethral resection of bladder tumor for primary non-muscle-invasive
bladder cancer.
Lasers Med Sci. 2023;38:44.
PubMed
Abstract available
Polymorphic renal transporters and cisplatin's toxicity in urinary bladder cancer
patients: current perspectives and future directions.
Med Oncol. 2023;40:80.
PubMed
Abstract available
Experimental analysis of bladder cancer-associated mutations in EP300 identifies
EP300-R1627W as a driver mutation.
Mol Med. 2023;29:7.
PubMed
Abstract available
[Expression pattern of the histone lysine demethylase family and its potential
role in bladder cancer: a multi-omics analysis].
Nan Fang Yi Ke Da Xue Xue Bao. 2022;42:1822-1831.
PubMed
Abstract available
Health-related quality of life after curative treatment for muscle-invasive
bladder cancer.
Nat Rev Urol. 2023 Jan 18. doi: 10.1038/s41585-022-00693.
PubMed
Abstract available
Urine cell-free DNA multi-omics to detect MRD and predict survival in bladder
cancer patients.
NPJ Precis Oncol. 2023;7:6.
PubMed
Abstract available
Inhibition of bladder cancer growth with homoharringtonine by inactivating
integrin alpha5/beta1-FAK/Src axis: A novel strategy for drug application.
Pharmacol Res. 2023;188:106654.
PubMed
Abstract available
The current use of the EORTC QLQ-NMIBC24 and QLQ-BLM30 questionnaires for the
assessment of health-related quality of life in bladder cancer patients: a
systematic review.
Qual Life Res. 2023 Jan 17. doi: 10.1007/s11136-022-03335.
PubMed
Abstract available
CD169(+) Macrophages Residing in the Draining Lymph Nodes and Infiltrating the
Tumor Play Opposite Roles in the Pathogenesis of Bladder Cancer.
Res Rep Urol. 2023;15:1-7.
PubMed
Abstract available
The association between gender, stage and prognosis in bladder cancer patients
undergoing radical cystectomy.
Scand J Urol. 2023 Jan 16:1-5. doi: 10.1080/21681805.2023.2166103.
PubMed
Abstract available
Properties of non-coding mutation hotspots as urinary biomarkers for bladder
cancer detection.
Sci Rep. 2023;13:1060.
PubMed
Abstract available
Feasibility of Early Evaluation for the Recurrence of Bladder Cancer after
Trans-Urethral Resection: A Comparison between Magnetic Resonance Imaging and
Multidetector Computed Tomography.
Tomography. 2022;9:25-35.
PubMed
Abstract available
Accuracy of FDG-PET/CT for Response Evaluation of Muscle-Invasive Bladder Cancer
following Neoadjuvant or Induction Chemotherapy.
Urol Int. 2023 Jan 19:1-7. doi: 10.1159/000528524.
PubMed
Abstract available
Efficacy of Intravesical Instillation Therapy with Low-Dose Tokyo-172 Bacillus
Calmette-Guerin to Prevent Recurrence of Non-Muscle-Invasive Bladder Cancer and
Treat Carcinoma in situ: A Multi-Institutional Retrospective Study.
Urol Int. 2023 Jan 16:1-9. doi: 10.1159/000527718.
PubMed
Abstract available
Performance of CellDetect for detection of bladder cancer: Comparison with urine
cytology and UroVysion.
Urol Oncol. 2023 Jan 13:S1078-1439(22)00497.
PubMed
Abstract available
Editorial: Cutting edge basic and clinical bladder cancer research - the IBCN
updates.
Urol Oncol. 2023 Jan 12:S1078-1439(22)00498.
PubMed
What is the role of CellDetect((R)) in detecting and monitoring bladder cancer?
Urologia. 2023 Jan 20:3915603221150036. doi: 10.1177/03915603221150036.
PubMed
Abstract available
Association Between Interleukin-6 Levels and Lymph Node Metastasis in Bladder
Cancer Patients.
World J Oncol. 2022;13:365-369.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by